Human Investing LLC Gilead Sciences, Inc. Transaction History

Human Investing LLC

$550 Million
Q3 2024

A detailed history of Human Investing LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Human Investing LLC holds 3,463 shares of GILD stock, worth $305,021. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,463

Previous 3,268 5.97%

Holding current value

$305,021

Previous $224,000 29.46%

% of portfolio

0.05%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$66.59 - $83.99 $12,985 - $16,378	195 Added 5.97%	3,463 $290,000
Q2 2024 Jul 17, 2024	SELL	$63.15 - $72.88 $30,248 - $34,909	-479 Reduced 12.78%	3,268 $224,000
Q1 2024 Apr 25, 2024	BUY	$71.58 - $87.29 $15,819 - $19,291	221 Added 6.27%	3,747 $274,000
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $86,018 - $97,547	-1,174 Reduced 24.98%	3,526 $285,000
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $32,681 - $35,656	-442 Reduced 8.6%	4,700 $352,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $83,002 - $94,676	-1,092 Reduced 17.52%	5,142 $396,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $11,519 - $13,123	-149 Reduced 2.33%	6,234 $517,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $116,351 - $167,040	-1,867 Reduced 22.63%	6,383 $0
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $80,379 - $91,813	1,350 Added 19.57%	8,250 $509,000
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $148,513 - $167,270	-2,573 Reduced 27.16%	6,900 $426,000
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $412,506 - $516,914	-7,122 Reduced 42.92%	9,473 $563,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $17,193 - $19,514	-265 Reduced 1.57%	16,595 $1.21 Million
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $1,015 - $1,095	15 Added 0.09%	16,860 $1.18 Million
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $8,441 - $9,223	-133 Reduced 0.78%	16,845 $1.16 Million
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $102,240 - $116,655	1,704 Added 11.16%	16,978 $1.1 Million
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $76,420 - $87,077	-1,349 Reduced 8.12%	15,274 $890,000
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $38,129 - $47,941	-614 Reduced 3.56%	16,623 $1.05 Million
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $10,778 - $12,516	149 Added 0.87%	17,237 $1.33 Million
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $1.82 Million - $2.33 Million	-29,101 Reduced 63.0%	17,088 $1.28 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $206,858 - $227,537	-3,357 Reduced 6.78%	46,189 $3 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $9,313 - $10,281	-149 Reduced 0.3%	49,546 $3.14 Million
Q2 2019 Aug 16, 2019	BUY	$61.87 - $69.38 $75,790 - $84,990	1,225 Added 2.53%	49,695 $3.36 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $117,056 - $131,133	1,872 Added 4.02%	48,470 $3.15 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.82 Million - $3.68 Million	46,598 New	46,598 $2.92 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.

Account

Human Investing LLC Gilead Sciences, Inc. Transaction History